CRH Medical Corp (TSE:CRH) had its price objective decreased by stock analysts at TD Securities from C$5.50 to C$4.00 in a research report issued on Monday. The brokerage presently has a “hold” rating on the stock. TD Securities’ price target would suggest a potential upside of 25.79% from the stock’s current price.

A number of other research firms also recently weighed in on CRH. Scotiabank downgraded CRH Medical Corp from an “outperform” rating to a “sector perform” rating and dropped their target price for the stock from C$10.00 to C$8.00 in a report on Friday, July 14th. Bloom Burton downgraded CRH Medical Corp from a “buy” rating to an “accumulate” rating in a report on Friday, July 14th. National Bank Financial dropped their target price on CRH Medical Corp from C$9.00 to C$7.00 in a report on Monday, July 17th. Royal Bank Of Canada lifted their target price on CRH Medical Corp from C$8.50 to C$10.00 and gave the stock a “sector perform” rating in a report on Monday, July 17th. Finally, Beacon Securities downgraded CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Thursday, August 3rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of C$5.06.

Shares of CRH Medical Corp (CRH) traded down 7.74% during trading on Monday, hitting $2.98. 479,619 shares of the stock were exchanged. The company has a market cap of $220.82 million and a P/E ratio of 30.41. The firm’s 50-day moving average is $3.17 and its 200 day moving average is $7.16. CRH Medical Corp has a 1-year low of $2.63 and a 1-year high of $12.35.

ILLEGAL ACTIVITY WARNING: “TD Securities Trims CRH Medical Corp (CRH) Target Price to C$4.00” was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/09/25/td-securities-trims-crh-medical-corp-crh-target-price-to-c4-00.html.

In related news, Director David Johnson sold 30,000 shares of the business’s stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of C$5.67, for a total value of C$170,100.00.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (TSE:CRH)

Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.